These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11881972)

  • 1. Effects of CCK2 receptor blockade on growth parameters in gastrointestinal tract and pancreas in rats.
    Björkqvist M; Norlén P; Kitano M; Chen D; Zhao CM; de la Cour CD; Gagnemo-Persson C; Håkanson R
    Pharmacol Toxicol; 2001 Oct; 89(4):208-13. PubMed ID: 11881972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cholecystokinin-2 receptor blockade on rat stomach ECL cells. A histochemical, electron-microscopic and chemical study.
    Chen D; Zhao CM; Norlén P; Björkqvist M; Ding XQ; Kitano M; Håkanson R
    Cell Tissue Res; 2000 Jan; 299(1):81-95. PubMed ID: 10654072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCK2 receptor antagonists: pharmacological tools to study the gastrin-ECL cell-parietal cell axis.
    Håkanson R; Ding XQ; Norlén P; Lindström E
    Regul Pept; 1999 Mar; 80(1-2):1-12. PubMed ID: 10235629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-lasting cholecystokinin(2) receptor blockade after a single subcutaneous injection of YF476 or YM022.
    Kitano M; Norlén P; Ding XQ; Nakamura S; Håkanson R
    Br J Pharmacol; 2000 Jun; 130(3):699-705. PubMed ID: 10821801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-course of deactivation of rat stomach ECL cells following cholecystokinin B/gastrin receptor blockade.
    Ding XQ; Lindström E; Håkanson R
    Br J Pharmacol; 1997 Sep; 122(1):1-6. PubMed ID: 9298521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholecystokinin-B/gastrin receptor blockade suppresses the activity of rat stomach ECL cells.
    Ding XQ; Lindström E; Håkanson R
    Pharmacol Toxicol; 1997 Jul; 81(1):19-25. PubMed ID: 9258980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the specificity and potency of a series of cholecystokinin-B/gastrin receptor antagonists in vivo.
    Ding XQ; Håkanson R
    Pharmacol Toxicol; 1996 Sep; 79(3):124-30. PubMed ID: 8884870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained cholecystokinin-B/gastrin receptor blockade does not impair basal or histamine-stimulated acid secretion in chronic gastric fistula rats.
    Ding XQ; Kitano M; Håkanson R
    Pharmacol Toxicol; 1998 Apr; 82(4):177-82. PubMed ID: 9584331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of three novel cholecystokinin-B/gastrin receptor antagonists: a study of their effects on rat stomach enterochromaffin-like cell activity.
    Ding XQ; Lindström E; Håkanson R
    Pharmacol Toxicol; 1997 Nov; 81(5):232-7. PubMed ID: 9396089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological analysis of CCK2 receptor antagonists using isolated rat stomach ECL cells.
    Lindström E; Björkqvist M; Håkanson R
    Br J Pharmacol; 1999 May; 127(2):530-6. PubMed ID: 10385255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mobilization of rat stomach ECL-cell histamine in response to short- or long-term treatment with omeprazole and/or YF 476 studied by gastric submucosal microdialysis in conscious rats.
    Konagaya T; Bernsand M; Norlén P; Håkanson R
    Br J Pharmacol; 2001 May; 133(1):37-42. PubMed ID: 11325792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversibility of cholecystokinin-B/gastrin receptor blockade: a study of the gastrin-ECL cell axis in the rat.
    Norlén P; Lindström E; Ding XQ; Kitano M; Håkanson R
    Pharmacol Toxicol; 1999 Apr; 84(4):159-64. PubMed ID: 10227066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic inhibitory effects of gastrin and histamine receptor antagonists on Helicobacter-induced gastric cancer.
    Takaishi S; Cui G; Frederick DM; Carlson JE; Houghton J; Varro A; Dockray GJ; Ge Z; Whary MT; Rogers AB; Fox JG; Wang TC
    Gastroenterology; 2005 Jun; 128(7):1965-83. PubMed ID: 15940630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cholecystokinin-B/gastrin receptor blockade on gastric acid secretion in conscious rats.
    Ding XQ; Håkanson R
    Pharmacol Toxicol; 1996 Dec; 79(6):324-30. PubMed ID: 9000260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCK1 and CCK2 receptors regulate gastric pepsinogen secretion.
    Blandizzi C; Lazzeri G; Colucci R; Carignani D; Tognetti M; Baschiera F; Del Tacca M
    Eur J Pharmacol; 1999 May; 373(1):71-84. PubMed ID: 10408253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of cholecystokinin-A receptor mRNA in pancreas and cholecystokinin-B receptor mRNA in oxyntic mucosa after porta-caval shunting in rats.
    Nylander AG; von Friesen CP; Monstein HJ; Yamada H; Chen D; Boketoft A; Håkanson R
    Pharmacol Toxicol; 1997 Mar; 80(3):147-51. PubMed ID: 9101588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of antagonist of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas.
    Dembiński A; Warzecha Z; Konturek SJ; Banas M; Cai RZ; Schally AV
    J Physiol Pharmacol; 1991 Sep; 42(3):263-77. PubMed ID: 1665365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YF476 is a new potent and selective gastrin/cholecystokinin-B receptor antagonist in vitro and in vivo.
    Takinami Y; Yuki H; Nishida A; Akuzawa S; Uchida A; Takemoto Y; Ohta M; Satoh M; Semple G; Miyata K
    Aliment Pharmacol Ther; 1997 Feb; 11(1):113-20. PubMed ID: 9042983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholecystokinin-B/gastrin receptors enhance wound healing in the rat gastric mucosa.
    Schmassmann A; Reubi JC
    J Clin Invest; 2000 Oct; 106(8):1021-9. PubMed ID: 11032862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YM022, a highly potent and selective CCKB antagonist inhibiting gastric acid secretion in the rat, the cat and isolated rabbit glands.
    Attoub S; Moizo L; Laigneau JP; Alchepo B; Lewin MJ; Bado A
    Fundam Clin Pharmacol; 1998; 12(3):256-62. PubMed ID: 9646057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.